All Photos(1)

Key Documents

COO/COA

View All Documentation

59452

(S)-2,2-Dimethyl-1,3-dioxolane-4-methanol p-toluenesulfonate

Name: (<I>S</I>)-2,2-Dimethyl-1,3-dioxolane-4-methanol p-toluenesulfonate
Brand: SIAL

purum, ≥99.0% (sum of enantiomers, GC)

Synonym(s):

2,3-Isopropylidene-sn-glycerol 1-tosylate, L-α,β-Isopropylideneglycerol-γ-tosylate

Sign Into View Organizational & Contract Pricing

All Photos(1)

About This Item

Empirical Formula (Hill Notation):

C₁₃H₁₈O₅S

CAS Number:

23735-43-5

Molecular Weight:

286.34

Beilstein/REAXYS Number:

89799

MDL number:

MFCD00063234

UNSPSC Code:

12352005

PubChem Substance ID:

329758669

grade

purum

assay

≥99.0% (sum of enantiomers, GC)

form

solid

optical activity

[α]20/D +7.5±0.5°, c = 2% in DMF

mp

29-31 °C

storage temp.

2-8°C

SMILES string

Cc1ccc(cc1)S(=O)(=O)OC[C@@H]2COC(C)(C)O2

InChI

1S/C13H18O5S/c1-10-4-6-12(7-5-10)19(14,15)17-9-11-8-16-13(2,3)18-11/h4-7,11H,8-9H2,1-3H3/t11-/m0/s1

InChI key

SRKDUHUULIWXFT-NSHDSACASA-N

Other Notes

Chiral building block, e.g. synthesis of GABOB

pictograms

GHS07

signalword

Warning

hcodes

H315,H319,H335

pcodes

P261 - P305 + P351 + P338

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

235.4 °F - closed cup

flash_point_c

113 °C - closed cup

ppe

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: a potential novel approach to the treatment of metastatic colorectal cancer.

Line S Tarpgaard et al.

Oncotarget, 7(37), 59441-59457 (2016-08-11)

It is now widely accepted that therapeutic antibodies targeting epidermal growth factor receptor (EGFR) can have efficacy in KRAS wild-type advanced colorectal cancer (CRC) patients. What remains to be ascertained is whether a subgroup of KRAS-mutated CRC patients might not

M.E. Jung et al.

Journal of the American Chemical Society, 102, 6304-6304 (1980)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service